Image

Fisetin in Mild Alzheimer's Disease

Fisetin in Mild Alzheimer's Disease

Recruiting
60 years and older
All
Phase 2
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.

Eligibility

Inclusion Criteria:

  • Patients from Charpennes Hospital included in the MEM-AURA cohort
  • Patients aged 60 years and older at inclusion
  • Patients with dementia due to clinically probable Alzheimer's disease, regardless of stage
  • Patients with a Mini-Mental State Evaluation (MMSE) score ≤ 26 at inclusion
  • Patients accompanied by a caregiver at inclusion

Exclusion Criteria:

  • \- Patients or caregivers who have expressed their opposition to the study
  • Patients living in institutions or nursing homes
  • Patients protected by law (under legal protection, guardianship, or conservatorship)

Early termination Criteria :

\- Patients or caregivers withdrawing their consent to participate during the study

Study details
    Alzheimer s Disease
    Alzheimer Dementia
    Alzheimer Dementia (AD)
    Alzheimer Disease
    Mild Cognitive Disorder
    Neurocognitive Disorders
    Mild
    Neurocognitive Disorder

NCT07279714

Sunnybrook Health Sciences Centre

13 May 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.